Table 3.
Compounds | Targeting | Mechanism | In Vitro/In Vivo Models | Comments | Refs |
---|---|---|---|---|---|
Incensole acetate (IA) | Oxidative stress induced by Aβ | Increased levels of the antioxidant enzyme HO-1 | Human olfactory bulb neural stem cells (hOBNSCs) |
The cellular model belongs to the olfactory system; therefore, we envision similar results in our proposed cellular model. |
[169] |
Curcumin loaded polymeric or lipid nanosuspensions | Oxidative stress | Elevation of total cellular glutathione levels and enhanced cell viability under oxidative stress | Normal and hypoxic olfactory ensheathing cells (OECs) |
The use of OECs (non-myelinating glial cells that wrap olfactory neurons) in hypoxic conditions enables a roadmap to improve the delivery of antioxidants through the nose-to-brain route. | [170,171,172] |
Saturated medium-chain fatty acid (MCFA) decanoic
acid (10:0) |
Oxidative stress | Upregulation of catalase activity and increase in mitochondrial citrate synthase | Neuroblastoma cells (SH-SY5Y cells) | MCFA decanoic acid has only been evaluated in human cell lines. These findings suggest it is worth testing them in AD patient-derived ONPs. | [173,174] |
Scutellarin (SC) | Oxidative stress and apoptosis | Enhances the levels of superoxide dismutase | L-Glu-treated HT22 cells/ AD mice induced by AlCl3 and D-gal | SC has shown antioxidant and antiapoptotic properties only in induced models of AD; thus, it would be interesting to evaluate these properties in a cellular model derived from AD patients. | [175] |
Curcumin and
Vitamin D3 |
Oxidative stress | Increased SOD enzyme activity and catalase enzyme expression | Primary neuronal cortical culture from rats treated with Aβ | Antioxidant combinations show a synergistic effect that could be tested in an ONP model. | [176] |
TM-10 (a ferulic acid derivative and a highly selective BuChE inhibitor) | Oxidative stress, Aβ aggregation, butyrylcholinesterase (BuChE) inhibition | Neuroprotective effect against Aβ42- mediated SH-SY5Y neurotoxicity, and autophagy induction. In mice, improves scopolamine-inducedmemory impairment | SH-SY5Y cell, U87 cell, AlCl3-induced zebrafish AD model, and mice treated with scopolamine | The search of Multi-Target-Directed-Ligands (MTDLs) has allowed fusing novel natural antioxidants derivatives and highly selective BuChE inhibitors. Thus, compounds with multiple biological activities are obtained, including ChE inhibitory activity, MAOs inhibitory potency, antioxidant activity, disaggregation effect on Aβ, and the ability to cross the blood−brain barrier. The use of AD patient-derived ONPs could be a valuable tool for validating these compounds in humans. | [177,178] |